Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(12 sites)
China
Chongqing Cancer Hospital, Chongqing, Chongqing Municipality Fujian Cancer Hospital, Fuzhou, Fujian Guangxi Medical University Cancer Hospital, Nanning, Guangxi Henan Provincial People's Hospital, Zhengzhou, Henan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Nanjing Drum Tower Hospital, Nanjing, Jiangsu West China Hospital of Sichuan University, Chengdu, Sichuan Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Fudan University Shanghai Cancer Center, Shanghai Shanxi Provincial Cancer Hospital, Taiyuan Henan Cancer Hospital, Zhengzhou